FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2891673104> ?p ?o ?g. }

• W2891673104 endingPage "e0203890" @default.
• W2891673104 startingPage "e0203890" @default.
• W2891673104 abstract "Rates of aging-related comorbidities, which require targeted medications to treat, have been shown to be increased among persons living with HIV compared with uninfected counterparts. Polypharmacy is generally defined as the concurrent use of 5 or more medications. We investigated polypharmacy prevalence for non-HIV medications over a 12-year period among HIV-positive and -negative participants in the Multicenter AIDS Cohort Study. Information regarding non-HIV medication use, HIV status, age, race/ethnicity, enrollment period, and medication insurance was obtained on 3,160 participants from semiannual visits between 2004 and 2016. Polypharmacy was defined as taking 5 or more non-HIV medications since the last health care visit. Generalized estimating equation models with repeated measures were produced overall and by HIV status to examine polypharmacy. The unadjusted prevalence of polypharmacy across all study visits was 18.6% and was higher among HIV-positive participants (24.4%) compared with HIV-negative participants (11.6%) (P < .0001). Among the 50 years and older age group, HIV-positive and HIV-negative participants had increases in polypharmacy over the observation period, from 38.4% to 46.8% (P = .0081) and from 16.7% to 46.0% (P < .0001), respectively. Among participants younger than 50, polypharmacy among HIV-positive participants remained stable (18.9% in 2004 to 17.3% in 2016; P = .5374) but increased among HIV-negative men (5.6% to 20.4%; P < .0001). After adjusting for age, race/ethnicity, and medication insurance, HIV-positive participants had a higher prevalence of polypharmacy than HIV-negative participants (25.3% vs 18.7%; P < .0001). Older age, white race, and having medication insurance coverage were also associated with greater polypharmacy. A convergence of polypharmacy prevalence was observed between HIV-positive and -negative participants at the end of observation. HIV-positive status was associated with an increased likelihood of polypharmacy, after adjusting for age, race/ethnicity, enrollment period, medication insurance, and study visit. Over time, polypharmacy prevalence increased among all participants, with converging rates between HIV-positive and -negative participants by the end of the observation period." @default.
• W2891673104 created "2018-09-27" @default.
• W2891673104 creator A5010897684 @default.
• W2891673104 creator A5015107487 @default.
• W2891673104 creator A5020267243 @default.
• W2891673104 creator A5043174070 @default.
• W2891673104 creator A5057100062 @default.
• W2891673104 creator A5076593688 @default.
• W2891673104 creator A5088885158 @default.
• W2891673104 date "2018-09-11" @default.
• W2891673104 modified "2023-10-18" @default.
• W2891673104 title "Prevalence and trends of polypharmacy among HIV-positive and -negative men in the Multicenter AIDS Cohort Study from 2004 to 2016" @default.
• W2891673104 cites W1830274026 @default.
• W2891673104 cites W189389301 @default.
• W2891673104 cites W1964008166 @default.
• W2891673104 cites W1964559625 @default.
• W2891673104 cites W1975329986 @default.
• W2891673104 cites W1976653861 @default.
• W2891673104 cites W1981343287 @default.
• W2891673104 cites W1990570958 @default.
• W2891673104 cites W1998800328 @default.
• W2891673104 cites W2009719424 @default.
• W2891673104 cites W2017615231 @default.
• W2891673104 cites W2022173703 @default.
• W2891673104 cites W2026477959 @default.
• W2891673104 cites W2078294291 @default.
• W2891673104 cites W2087655403 @default.
• W2891673104 cites W2110724572 @default.
• W2891673104 cites W2128043538 @default.
• W2891673104 cites W2132228483 @default.
• W2891673104 cites W2139508877 @default.
• W2891673104 cites W2158298030 @default.
• W2891673104 cites W2158666805 @default.
• W2891673104 cites W2170821252 @default.
• W2891673104 cites W2508894633 @default.
• W2891673104 cites W2767415052 @default.
• W2891673104 cites W2791013669 @default.
• W2891673104 cites W2803251184 @default.
• W2891673104 doi "https://doi.org/10.1371/journal.pone.0203890" @default.
• W2891673104 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6133387" @default.
• W2891673104 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30204807" @default.
• W2891673104 hasPublicationYear "2018" @default.
• W2891673104 type Work @default.
• W2891673104 sameAs 2891673104 @default.
• W2891673104 citedByCount "48" @default.
• W2891673104 countsByYear W28916731042018 @default.
• W2891673104 countsByYear W28916731042019 @default.
• W2891673104 countsByYear W28916731042020 @default.
• W2891673104 countsByYear W28916731042021 @default.
• W2891673104 countsByYear W28916731042022 @default.
• W2891673104 countsByYear W28916731042023 @default.
• W2891673104 crossrefType "journal-article" @default.
• W2891673104 hasAuthorship W2891673104A5010897684 @default.
• W2891673104 hasAuthorship W2891673104A5015107487 @default.
• W2891673104 hasAuthorship W2891673104A5020267243 @default.
• W2891673104 hasAuthorship W2891673104A5043174070 @default.
• W2891673104 hasAuthorship W2891673104A5057100062 @default.
• W2891673104 hasAuthorship W2891673104A5076593688 @default.
• W2891673104 hasAuthorship W2891673104A5088885158 @default.
• W2891673104 hasBestOaLocation W28916731041 @default.
• W2891673104 hasConcept C126322002 @default.
• W2891673104 hasConcept C137403100 @default.
• W2891673104 hasConcept C142462285 @default.
• W2891673104 hasConcept C144024400 @default.
• W2891673104 hasConcept C149923435 @default.
• W2891673104 hasConcept C19165224 @default.
• W2891673104 hasConcept C201903717 @default.
• W2891673104 hasConcept C203014093 @default.
• W2891673104 hasConcept C2779898580 @default.
• W2891673104 hasConcept C2993143319 @default.
• W2891673104 hasConcept C3013748606 @default.
• W2891673104 hasConcept C36434225 @default.
• W2891673104 hasConcept C71924100 @default.
• W2891673104 hasConcept C72563966 @default.
• W2891673104 hasConcept C74909509 @default.
• W2891673104 hasConceptScore W2891673104C126322002 @default.
• W2891673104 hasConceptScore W2891673104C137403100 @default.
• W2891673104 hasConceptScore W2891673104C142462285 @default.
• W2891673104 hasConceptScore W2891673104C144024400 @default.
• W2891673104 hasConceptScore W2891673104C149923435 @default.
• W2891673104 hasConceptScore W2891673104C19165224 @default.
• W2891673104 hasConceptScore W2891673104C201903717 @default.
• W2891673104 hasConceptScore W2891673104C203014093 @default.
• W2891673104 hasConceptScore W2891673104C2779898580 @default.
• W2891673104 hasConceptScore W2891673104C2993143319 @default.
• W2891673104 hasConceptScore W2891673104C3013748606 @default.
• W2891673104 hasConceptScore W2891673104C36434225 @default.
• W2891673104 hasConceptScore W2891673104C71924100 @default.
• W2891673104 hasConceptScore W2891673104C72563966 @default.
• W2891673104 hasConceptScore W2891673104C74909509 @default.
• W2891673104 hasIssue "9" @default.
• W2891673104 hasLocation W28916731041 @default.
• W2891673104 hasLocation W28916731042 @default.
• W2891673104 hasLocation W28916731043 @default.
• W2891673104 hasLocation W28916731044 @default.
• W2891673104 hasLocation W28916731045 @default.
• W2891673104 hasLocation W28916731046 @default.
• W2891673104 hasOpenAccess W2891673104 @default.

• next